BRIEF-Fusen Pharmaceutical Company Sees Decrease In Profit Attributable For Fy2019 By Over 45%

March 16 (Reuters) - Fusen Pharmaceutical Company Ltd :

* EXPECTED TO RECORD A DECREASE IN PROFIT ATTRIBUTABLE FOR FY2019 BY OVER 45%

* EXPECTED RESULT DUE TO INCREASED INVESTMENTS IN RESEARCH AND DEVELOPMENT, AMONG OTHER THINGS Source text for Eikon: Further company coverage: